Substance or medication induced bipolar disorder diagnostic criteria: Difference between revisions

	Bipolar disorder Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Causes
Differentiating Bipolar disorder from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria Bipolar I Bipolar II Cyclothymic Disorder Substance/Medication-Induced Bipolar Disorder Bipolar Disorder Due to Another Medical Condition Unspecified Bipolar Disorder
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Substance or medication induced bipolar disorder diagnostic criteria On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Substance or medication induced bipolar disorder diagnostic criteria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Substance or medication induced bipolar disorder diagnostic criteria
CDC on Substance or medication induced bipolar disorder diagnostic criteria
Substance or medication induced bipolar disorder diagnostic criteria in the news
Blogs on Substance or medication induced bipolar disorder diagnostic criteria
Directions to Hospitals Treating Bipolar disorder
Risk calculators and risk factors for Substance or medication induced bipolar disorder diagnostic criteria

Latest revision as of 12:47, 12 November 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

“

A. A prominent and persistent disturbance in mood that predominates in the clinical picture and is characterized by elevated, expansive, or irritable mood, with or without depressed mood, or markedly diminished interest or pleasure in all, or almost all, activities.

AND

B. There is evidence from the history, physical examination, or laboratory findings of both (1)and (2):

1. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication.

2. The involved substance/medication is capable of producing the symptoms in Criterion A.

AND

C. The disturbance is not better explained by a bipolar or related disorder that is not substance/medication-induced. Such evidence of an independent bipolar or related disorder could include the following:

The symptoms precede the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced bipolar and related disorder (e.g., a history of recurrent non-substance/medication-related episodes).

AND

AND

E. The disturbance causes clinically significant distress or impairment in social, occupational,or other important areas of functioning.

”

↑ Diagnostic and statistical manual of mental disorders : DSM-5. Washington, D.C: American Psychiatric Association. 2013. ISBN 0890425558.

@@ Line 29: / Line 29: @@
 *E. The disturbance causes clinically significant distress or impairment in social, occupational,or other important areas of functioning.
 }}
-==Differential Diagnosis==
-*Intoxication induced [[delirium]]
-*Medication side effects
-*Substance induced delirium<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref>
 ==References==